Table 2.
Shift to other substances and initiation of a formal drug treatment because of problems with availability of the main drug during the COVID-19 pandemic.
| Main drug | |||||
|---|---|---|---|---|---|
| Heroin (n = 103) | Cannabis (n = 109) | Cocaine (n = 75) | Total (n = 287) | ||
| No change in consumption of main drug | n | 83 | 90 | 54 | 227 |
| % | 83.0% | 84.1% | 73.0% | 80.8% | |
| Shift to legal substances (alcohol) | n | 12 | 8 | 6 | 26 |
| % | 12.0% | 7.5% | 8.1% | 9.30% | |
| Shift to illegally acquired medications, maintenance drugs | n | 8 | 2 | 3 | 13 |
| % | 8.0% | 1.0% | 4.1% | 4.6% | |
| Shift to synthetic cannabinoids | n | 0 | 1 | 1 | 2 |
| % | 0.0% | 0.9% | 1.4% | 0.7% | |
| Shift to synthetic stimulants | n | 0 | 2 | 0 | 2 |
| % | 0.0% | 1.9% | 0.0% | 0.7% | |
| Shift to new synthetic opioids | n | 1 | 0 | 0 | 1 |
| % | 1.0% | 0.0% | 0.0% | 0.4% | |
| Started a new episode of opioid maintenance treatment because of COVID-19 pandemic |
n % |
7 7.0% |
4 3.7% |
0 0.0% |
11 3.9% |
| Started detoxification treatment because of COVID-19 pandemic | n | 6 | 5 | 5 | 16 |
| % | 6.0% | 4.7% | 6.8% | 5.7% | |
Note that some responses were missing for some questions.